Followers | 39 |
Posts | 2870 |
Boards Moderated | 0 |
Alias Born | 12/06/2003 |
Thursday, August 16, 2018 12:54:50 PM
This is a separate release picked up by my broker:
BioTime to Present Data at the Military Health System Research Symposium
BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that it will be presenting a poster at the Military Health System Research Symposium (MHSRS) from August 20-23, 2018 in Kissimmee, Florida.
The poster presentation is titled, "Next generation disease modifying viscosupplementation to delay or prevent invasive surgery in combat-related Post Traumatic Osteoarthritis (PTOA)." Dr. Thomas Zarembinski, PhD, MBA and Head of External R&D for BioTime will present the data on Tuesday, August 21(st) during the Extremity and Craniomaxillofacial Regeneration session.
The poster describes the ability of a novel DNA-based small molecule to decrease cartilage degradation and turnover normally associated with osteoarthritis as well as the ability of BioTime's proprietary HyStem(R) drug delivery platform to modulate its release over an extended period.
Hystem(R) is BioTime's proprietary hydrogel platform that is designed to facilitate the delivery of cells and molecules. When delivering molecules, it can slowly release the compound in the target area over an extended period of time potentially providing several advantages such as longer term therapeutic benefit. The delivery of cells and molecules is a core area of focus for BioTime. "The data being presented is encouraging and allows BioTime to further explore potential disease modifying therapies for the treatment of osteoarthritis," said Dr. Zarembinski, Head of External R&D for BioTime.
It's getting harder and harder for me to tell much of the technology from the two companies apart. The particular description of treatment for osteoarthritis presents another elusive dream for my wife's particularly nightmarish fast degeneration with osteoarthritis that is s'posed to be slow:
From the intern?,helper?,nurse practitioner? rheumatologist:
"You certainly don't need a knee replacement, maybe you have an allergy to the hyaluronic acid or the other steroid, I have a new one..."
Obviously not a real quote but most tantalizing of all is that all pain and other debilitating effects of osteoarthritis was removed from our Border Collie who was on her deathbed by a daily veterinary prescribed pill that warns it is not for humans. It is a vastly different technology from a complex drug known about for over a decade.
And on and on the merry-go-round circles around.
Best, Terry
Recent LCTX News
- Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop • Business Wire • 09/18/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 10:24:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:10:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:00:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:30:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 01:11:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/15/2024 04:15:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:39:15 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/14/2024 08:36:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:15:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:10:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:05:26 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/07/2024 10:17:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:10:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:27:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:30:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 02:27:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 11:58:18 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/08/2024 11:57:07 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/06/2024 02:25:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:20:38 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM